Valuations looking reasonable, but earnings growth remains a concern: Dipan Mehta

Valuations looking reasonable, but earnings growth remains a concern: Dipan Mehta

“Specifically, we do not have a stock list ready, like a shopping list per se. We are still observing what has happened in the quarter which has gone by,” says Dipan Mehta, Director, Elixir Equities.What does one do, just sit it out and watch or do you think it is time now to selectively start … Read more

3 top stock recommendations from Rajesh Palviya for next week

3 top stock recommendations from Rajesh Palviya for next week

“For this September series, we expect the range for September series for Nifty is 24,800 on the downside and on the higher side 25,600, this is going to be the possible range for Nifty. For Bank Nifty, the immediate supply zone which is placed is around 51,500 which is very important level to cross on … Read more

Dabur India, PI Industries could rally 19-26% return on above normal monsoon: Siddhartha Khemka

Dabur India, PI Industries could rally 19-26% return on above normal monsoon: Siddhartha Khemka

The India Meteorological Department (IMD) announced its stage-2 long-range forecast for southwest monsoon 2024. It has retained its outlook of an above-normal monsoon this year. It expects rainfall in the upcoming monsoon to be at an eight-year high of 106% (with an error margin of +/-5%) of the long-period average of 870mm for the four-month … Read more

Can Vodafone Idea stock trade above Rs 20 in next one year? Hemang Jani answers

Can Vodafone Idea stock trade above Rs 20 in next one year? Hemang Jani answers

“I think there is a growth in terms of volume, given the kind of appetite that people have for jewellery and also, we feel that you will see stable margins once there is a little bit of stability in the gold prices,” says Hemang Jani, Independent Market Expert.Now Goldman Sachs has come out with a … Read more

We would keep 12-15% cash and wait for stocks that would outperform over next 12 months: Sandip Sabharwal

We would keep 12-15% cash and wait for stocks that would outperform over next 12 months: Sandip Sabharwal

Sandip Sabharwal, asksandipsabharwal.com, says “the markets have corrected and people are correlating it to what might happen in the election. I do not think that is the right way to do it. I think markets fall under their own weight when they become overweight. So, the Indian market became overweight and is correcting a bit. … Read more

PSU banks will continue re-rating; SBI, ICICI Bank & Axis Bank poised for a breakout: Laurence Balanco

PSU banks will continue re-rating; SBI, ICICI Bank & Axis Bank poised for a breakout: Laurence Balanco

“You can see from foreign flows perspective that that rebound in China is detracting from some of the investment in India. I do not think it changes the longer-term trends, but we are in one of those holding patterns similar to the fourth quarter of 2023,” says Laurence Balanco, CLSA.What is the take on India … Read more

Should you be bullish on pharma sector in near term? Sudip Bandyopadhyay answers

Should you be bullish on pharma sector in near term? Sudip Bandyopadhyay answers

“It is just that we have a strong domestic investor sentiment and about $2 billion per month is the incremental SIP which I think to an extent is ensuring that markets are not really crashing,” says Sudip Bandyopadhyay, Inditrade Capital. Just wanted to understand from you that from the earnings, which sector that you are … Read more

Tailwinds at the right time: 7 pharma stocks with an upside potential up to 31 %

Tailwinds at the right time: 7 pharma stocks with an upside potential up to 31 %

After the IT sector it was the pharmaceutical sector which came into limelight as another big exporter from India. The valuations exploded and for a decade, pharma stocks were big wealth creators and also strong out performers. However, post 2014, both in terms of bottomline and stock price performance, pharma stocks had been under pressure. … Read more

Government likely to extend export benefits under RoDTEP scheme for pharma, steel, chemical sectors

Government likely to extend export benefits under RoDTEP scheme for pharma, steel, chemical sectors

The government is expected to extend export benefits under the RoDTEP scheme to iron and steel, chemicals and pharmaceutical sectors beyond September 30, according to a senior official. In December 2022, the government extended the benefits under the Remission of Duties and Taxes on Exported Products (RoDTEP) Scheme to chemicals, pharmaceuticals and products of iron … Read more

Defence PSU stocks may give good return in the short term: Dipan Mehta

Defence PSU stocks may give good return in the short term: Dipan Mehta

“Question is whether you will get an allotment or not because of the heavy over subscription. But, from retail investor perspective, it is a good opportunity and perhaps you could even add some stock post listing,” says Dipan Mehta, Director, Elixir Equities.Mankind Pharma, an offering from the pharma sector after a while, wanted to understand … Read more